Benoson n indications
this preparations are indicated for the treatment of the following conditions where secondary bacterial infection is present, suspected, or likely to occur: eczema in adults and children (aged 2 years and over), including atopic and discoid eczemas; prurigo nodularis; psoriasis (excluding widespread plaque psoriasis); neurodermatoses including lichen simplex and lichen planus; seborrhoeic dermatitis; contact sensitivity reactions; insect bite reactions; and anal and genital intertrigo.
Benoson n interactions
Following significant systemic absorption, neomycin sulphate can intensify and prolong the respiratory depressant effects of neuromuscular blocking agents.
Benoson n side effects
Prolonged and intensive treatment with highly active corticosteroid preparations may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or when skin folds are involved
As with other topical corticosteroids, prolonged use of large amounts or treatment of extensive areas can result in sufficient systemic absorption to produce suppression of the HPA axis and the clinical features of Cushing’s syndrome. These effects are more likely to occur in infants and children, and if occlusive dressings are used. In infants the napkin may act as an occlusive dressing.
In rare instances, treatment of psoriasis with corticosteroids (or its withdrawal) is thought to have provoked the pustular form of the disease.
There are reports of local skin burning, pruritus, pigmentation changes, allergic contact dermatitis and hypertrichosis with topical steroids.
The preparations are usually well tolerated, but if signs of hypersensitivity appear, application should be stopped immediately.
Exacerbation of symptoms may occur.
Benoson n contraindications
•Rosacea.
•Acne vulgaris.
•Perioral dermatitis.
•Perianal and genital pruritus.
•Primary cutaneous viral infections (e.g. herpes simplex, chickenpox).
•Hypersensitivity to any component of the preparation.
•Use is not indicated in treatment of primary infected skin lesions caused by infection with fungi or bacteria; primary or secondary infections due to yeast; or secondary infections due to Pseudomonas or Proteus species.
•Dermatoses in children under 2 years of age, including dermatitis and napkin eruptions. A possibility of increased absorption exists in very young children, thus is not recommended for use in neonates and infants (up to 2 years). In neonates and infants, absorption by immature skin may be enhanced, and renal function may be immature.
•Preparations containing neomycin should not be used for the treatment of otitis externa when the ear-drum is perforated, because of the risk of ototoxicity.
•Due to the known ototoxic and nephrotoxic potential of neomycin sulphate, usage in large quantities or on large areas for prolonged periods of time is not recommended in circumstances where significant systemic absorption may occur.
Active ingredient matches for Benoson n:
Betamethasone valerate/neomycin sulfate in Indonesia.
List of Benoson n substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Betaderm n (Brazil) | |
| Betamethasone N. | |
| Betamethasone valerate/neomycin sulfate (Hongkong, Thailand) | |
| Betneval-neomycine (France) | |
| Célestoderm néomycine (France) | |
| Derzid-N 膚炎消 - N (Hongkong) | |
| Etbute (Vietnam) | |
| Etbute 1 tube x 15 g | |
| Valisone N | |
References
- DailyMed. "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "BETAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "betamethasone". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Benoson n are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Benoson n. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
